Biological markers in superficial bladder tumors and their prognostic significance
- PMID: 10696257
- DOI: 10.1016/s0094-0143(05)70246-9
Biological markers in superficial bladder tumors and their prognostic significance
Abstract
This article reviews the literature on some of the available biomarkers such as p53 and its down-stream effector p21 on superficial bladder tumor biology and their prognostic significance. The role of p53 tumor suppressor gene is controversial in superficial bladder cancer, possibly because analyzing one single effector of a pathway might hide the role of downstream effectors. The aggressiveness of this condition is related to proliferative activity as measured by Ki-67. Further studies are still necessary to draw definitive conclusions about the role of these different biological markers in superficial bladder cancer.
Similar articles
-
Correlation and prognostic significance of p53, p21WAF1/CIP1 and Ki-67 expression in patients with superficial bladder tumors treated with bacillus Calmette-Guerin intravesical therapy.J Urol. 1999 Mar;161(3):792-8. J Urol. 1999. PMID: 10022686
-
p53 mutations in bladder tumors inactivate the transactivation of the p21 and Bax genes, and have a predictive value for the clinical outcome after bacillus Calmette-Guerin therapy.J Urol. 1999 Jul;162(1):69-73. doi: 10.1097/00005392-199907000-00017. J Urol. 1999. PMID: 10379742 Clinical Trial.
-
Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.Clin Cancer Res. 1999 Dec;5(12):4079-84. Clin Cancer Res. 1999. PMID: 10632343
-
A critical analysis of the use of p53 as a marker for management of bladder cancer.Urol Clin North Am. 2000 Feb;27(1):75-82, ix. doi: 10.1016/s0094-0143(05)70236-6. Urol Clin North Am. 2000. PMID: 10696247 Review.
-
P53 in bladder cancer: mechanism of action, prognostic value, and target for therapy.Urology. 2001 May;57(5):852-9. doi: 10.1016/s0090-4295(01)00968-2. Urology. 2001. PMID: 11337281 Review. No abstract available.
Cited by
-
Role of F-fluoro-2-deoxyglucose Positron Emission Tomography in Gastric GIST: Predicting Malignant Potential Pre-operatively.J Gastric Cancer. 2011 Sep;11(3):173-9. doi: 10.5230/jgc.2011.11.3.173. Epub 2011 Sep 29. J Gastric Cancer. 2011. PMID: 22076223 Free PMC article.
-
Association study of the G-protein beta3 subunit C825T polymorphism with disease progression in patients with bladder cancer.World J Urol. 2005 Sep;23(4):279-86. doi: 10.1007/s00345-005-0006-6. Epub 2005 Nov 8. World J Urol. 2005. PMID: 16133558
-
Correlation between Semi-Quantitative (18)F-FDG PET/CT Parameters and Ki-67 Expression in Small Cell Lung Cancer.Nucl Med Mol Imaging. 2016 Mar;50(1):24-30. doi: 10.1007/s13139-015-0363-z. Epub 2016 Jan 5. Nucl Med Mol Imaging. 2016. PMID: 26941856 Free PMC article.
-
The health economics of bladder cancer: a comprehensive review of the published literature.Pharmacoeconomics. 2003;21(18):1315-30. doi: 10.1007/BF03262330. Pharmacoeconomics. 2003. PMID: 14750899
-
[Value of biomarkers in urology].Urologe A. 2010 Apr;49(4):547-59. doi: 10.1007/s00120-010-2286-8. Urologe A. 2010. PMID: 20376654 Review. German.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous